You searched for lawsuits - Page 8 of 11

Narrowed Stemgenex suit proceeds as court implies stem cell clinic loopholes

April 19, 2017 / Professor Paul Knoepfler, Ph.D. / 13 Comments

Can California stem cell clinics make questionable marketing claims about their experimental, non-FDA approved offerings as long as they are not demonstrably false? Do such clinics not bear any legal requirement to provide informed consent to patients? A new court ruling raises such striking questions. San Diego stem cell clinic Stemgenex sells non-FDA approved experimental stem […]

Narrowed Stemgenex suit proceeds as court implies stem cell clinic loopholes Read More »

Stemedica sued by board member over alleged mishandling of funds

April 11, 2017 / Professor Paul Knoepfler, Ph.D. / 3 Comments

Dr.-Anthony-M.-Marlon-Stemedica-e1491941925842

Stem cell clinic biotech Stemedica has just been sued by one of its own board members based on allegations related to money the company raised, according to CourtHouseNews. The actual suit, filed by an investment company Tiara Holdings and board member Anthony Marlon, can be read here. CourtHouseNews writes: “Tiara Holdings II LLC sued Stemedica Cell

Stemedica sued by board member over alleged mishandling of funds Read More »

LA Times Reports Stemgenex Doc Gets 3-Year Probation from State Medical Board

April 1, 2017 / Professor Paul Knoepfler, Ph.D. / 5 Comments

The world of stem cell clinics is on edge right now with a number of negative patient outcomes reported and lawsuits in play such as San Diego stem cell clinic Stemgenex being a defendant in a proposed class action lawsuit focusing in part on alleged problematic marketing claims on their website (see archived posts on the lawsuit).

LA Times Reports Stemgenex Doc Gets 3-Year Probation from State Medical Board Read More »

NEJM paper links 3 blinded patients to US Stem Cell clinic

March 15, 2017 / Professor Paul Knoepfler, Ph.D. / 11 Comments

stem-cells-eyes, stem cell therapy side effects.

Do three blinded US Stem Cell clinic patients with major or complete vision loss constitute a significant adverse outcome? I would say so and a new paper details how this happened apparently at a particular publically-traded South Florida stem cell clinic business. You can see the damaged retinas of one such patient below in an image

NEJM paper links 3 blinded patients to US Stem Cell clinic Read More »

What’s the deal with US Stem Cell Inc stock?

March 8, 2017 / Professor Paul Knoepfler, Ph.D. / 2 Comments

The stem cell clinic business US Stem Cell Inc., formerly known as Bioheart, has seen its stock take a rollercoaster ride recently include a big run up and now today a big drop so what’s the scoop? US Stem Cell, which includes a few subsidiaries such as US Stem Cell Clinic, focuses on the use

What’s the deal with US Stem Cell Inc stock? Read More »

Update on patients lawsuit against stem cell clinic, Stemgenex

January 23, 2017 / Professor Paul Knoepfler, Ph.D. / 6 Comments

The website Law360 has an interesting update on the proposed class action lawsuit against the San Diego stem cell clinic Stemgenex. Note that it seems you can read the full Law360 article without a subscription if you open the site in Chrome as your web browser. See more background on Stemgenex and on this case

Update on patients lawsuit against stem cell clinic, Stemgenex Read More »

Clinics can’t retract problems like stem cell facelift gone wrong

January 4, 2017 / Professor Paul Knoepfler, Ph.D. / 8 Comments

What happens for patients and clinics after a stem cell facelift gone wrong? What about other cell injection problems? Cell therapies raise new challenges and risks. You can stop taking a pill or an injection treatment. However, you can’t stop or retract stem cell treatments if there’s a bad side effect. Unlike other kinds of

Clinics can’t retract problems like stem cell facelift gone wrong Read More »

Stem Cell Predictions for 2017

December 29, 2016 / Professor Paul Knoepfler, Ph.D. / 7 Comments

Each year I make a list of predictions for the stem cell and regenerative medicine field for the coming new year. Later in this post I list my top 20 stem cell predictions for 2017. In looking at my past predictions I realized this will now be my 7th year doing stem cell/regenerative medicine yearly predictions.

Stem Cell Predictions for 2017 Read More »

Grading my stem cell predictions for 2016: how’d I do?

December 26, 2016 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Below are the 2016 stem cell predictions I made last year and their status now color-coded near year’s end. Green is right, orange is mixed bag, and red is flat out wrong. Overall, I did better than most past years with only having entirely blown it on four. Stay tuned later this week for my 2017 predictions,

Grading my stem cell predictions for 2016: how’d I do? Read More »

Stemgenex motion to dismiss aims to rebut stem cell suit claims

December 8, 2016 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Motion-to-dismiss-Stemgenex-e1481238888500

San Diego-based stem cell business Stemgenex is the subject of a suit over allegations about stem cell treatments. The company has now filed a motion to dismiss the case. To me as a non-attorney, the Stemgenex motion to dismiss seems to emphasize overall vagueness of the plaintiff’s case and argues in part that there is insufficient detailed support of each claim. From

Stemgenex motion to dismiss aims to rebut stem cell suit claims Read More »

Search Results for: lawsuits